文献速递糖尿病

新诊断2型糖尿病的亚型与并发症风险:美国电子健康记录分析

Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA.
PubMed 文献 · Diabetologia · 2026-02-21

该研究基于美国Epic Cosmos平台2012—2023年727,076例新诊断2型糖尿病成人数据,应用队列研究开发的分类模型识别亚型并分析其社会人口学分布。与轻度肥胖相关糖尿病相比,严重胰岛素缺乏型糖尿病视网膜病变、神经病变、肾病及心血管并发症风险均更高。研究支持利用常规电子健康记录数据在诊断时刻画患者异质性。

要点

  • 电子健康记录可识别新诊断2型糖尿病亚型并评估并发症风险差异。
  • 严重胰岛素缺乏型糖尿病较轻度肥胖相关型糖尿病微血管和大血管并发症风险更高。
  • SIDD和MOD在西班牙裔及非西班牙裔黑人中患病率高于非西班牙裔白人。

核心结论

  • 通过电子健康记录识别的2型糖尿病不同亚型,其血管并发症风险存在差异。

研究设计与样本

  • 基于Epic Cosmos研究平台2012—2023年美国50州及哥伦比亚特区727,076例≥18岁新诊断2型糖尿病成人的电子健康记录分析。
  • 将队列研究开发的分类模型应用于该人群,以研究亚型的社会人口学分布。
  • 采用Cox比例风险回归模型(校正年龄和性别)评估微血管和大血管并发症发生率。

主要发现

  • 新诊断个体平均年龄64.4岁(SD 13.3),女性占52%。
  • 亚型分布:严重胰岛素缺乏型糖尿病(SIDD)21.6%,轻度肥胖相关糖尿病(MOD)23.8%,轻度年龄相关糖尿病40.9%,混合型13.7%。
  • 与MOD相比,SIDD的视网膜病变HR 2.83(95% CI 2.73, 2.93)、神经病变HR 1.57(95% CI 1.54, 1.60)、肾病HR 1.34(95% CI 1.32, 1.37)。
  • 与MOD相比,SIDD的严重ASCVD HR 1.49(95% CI 1.46, 1.53)、其他ASCVD HR 1.23(95% CI 1.21, 1.25)、心力衰竭HR 1.17(95% CI 1.15, 1.20)。
  • SIDD和MOD在西班牙裔(分别为28.4%和30.1%)及非西班牙裔黑人(分别为25.5%和30.0%)中较非西班牙裔白人(分别为20.1%和21.6%)更常见。

关键数值与推荐

  • SIDD较MOD的视网膜病变风险HR 2.83(95% CI 2.73, 2.93)。
  • SIDD较MOD的神经病变风险HR 1.57(95% CI 1.54, 1.60)。
  • SIDD较MOD的肾病风险HR 1.34(95% CI 1.32, 1.37)。
  • SIDD较MOD的严重ASCVD风险HR 1.49(95% CI 1.46, 1.53)。
  • SIDD较MOD的心力衰竭风险HR 1.17(95% CI 1.15, 1.20)。

临床怎么用

  • 可利用常规电子健康记录数据在新诊断时对2型糖尿病进行亚型划分。
  • 对识别为SIDD的患者应加强微血管和大血管并发症的风险监测与管理。
  • 关注西班牙裔及非西班牙裔黑人人群中SIDD和MOD的较高患病率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Data-driven subtyping of type 2 diabetes has not been translated into clinical practice due to the lack of routine fasting glucose and insulin measurements. We aimed to identify type 2 diabetes subtypes in clinical settings using electronic health records and study their epidemiology. METHODS: We identified 727,076 adults (≥18 years) with newly diagnosed type 2 diabetes from Epic Cosmos research platform data across all 50 states and the District of Columbia between 2012 and 2023. Classification models developed in cohort studies were applied to study the sociodemographic distribution of subtypes. Cox proportional hazards regression models, adjusted for age and sex, were used to assess the rates of microvascular complications (retinopathy, neuropathy and nephropathy) and macrovascular complications (severe atherosclerotic cardiovascular disease [ASCVD], other ASCVD and heart failure). RESULTS: Among newly diagnosed individuals (mean age 64.4 years [SD 13.3], 52% female), 21.6% were classified as having severe insulin-deficient diabetes (SIDD), 23.8% were classified as having mild obesity-related diabetes (MOD), 40.9% were classified as having mild age-related diabetes and 13.7% were classified as having the mixed subtype. Compared with those classified as having MOD, individuals classified as having SIDD had higher HRs for retinopathy (HR 2.83; 95% CI 2.73, 2.93), neuropathy (HR 1.57; 95% CI 1.54, 1.60), nephropathy (HR 1.34; 95% CI 1.32, 1.37), severe ASCVD (HR 1.49; 95% CI 1.46, 1.53), other ASCVD (HR 1.23; 95% CI 1.21, 1.25) and heart failure (HR 1.17; 95% CI 1.15, 1.20). SIDD and MOD were more prevalent among Hispanics (28.4% and 30.1%, respectively) and non-Hispanic Black people (25.5% and 30.0%, respectively) compared with non-Hispanic White people (20.1% and 21.6%, respectively), and were also more prevalent in the District of Columbia and Utah, respectively, compared with the rest of the country. CONCLUSIONS/INTERPRETATION: Individuals with different type 2 diabetes subtypes, identified through electronic health records, differ in terms of their risk of vascular complications. These findings support leveraging routine electronic health record data to improve the characterisation of patient heterogeneity at the time of diabetes diagnosis.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Li Z, Liu S, Ho JC, et al. Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA. Diabetologia. 2026. PMID: 41723302. doi:10.1007/s00125-026-06687-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。